Zymeworks Inc.
ZYME
$12.57
$0.010.08%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 93.38M | 76.30M | 62.20M | 62.71M | 50.46M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 93.38M | 76.30M | 62.20M | 62.71M | 50.46M |
| Cost of Revenue | 138.32M | 135.32M | 123.48M | 119.91M | 130.15M |
| Gross Profit | -44.93M | -59.02M | -61.28M | -57.20M | -79.69M |
| SG&A Expenses | 62.70M | 61.51M | 60.14M | 63.26M | 69.29M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 201.02M | 196.83M | 183.63M | 183.17M | 199.44M |
| Operating Income | -107.63M | -120.52M | -121.43M | -120.46M | -148.98M |
| Income Before Tax | -107.17M | -116.61M | -118.02M | -115.98M | -127.86M |
| Income Tax Expenses | 6.51M | 6.08M | -4.35M | -3.47M | -1.88M |
| Earnings from Continuing Operations | -113.68 | -122.70 | -113.67 | -112.51 | -125.97 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -113.68M | -122.70M | -113.67M | -112.51M | -125.97M |
| EBIT | -107.63M | -120.52M | -121.43M | -120.46M | -148.98M |
| EBITDA | -98.12M | -111.84M | -113.53M | -111.51M | -139.31M |
| EPS Basic | -1.50 | -1.62 | -1.51 | -1.52 | -1.79 |
| Normalized Basic EPS | -0.74 | -0.82 | -0.84 | -0.84 | -1.14 |
| EPS Diluted | -1.50 | -1.62 | -1.51 | -1.53 | -1.79 |
| Normalized Diluted EPS | -0.74 | -0.82 | -0.84 | -0.84 | -1.14 |
| Average Basic Shares Outstanding | 302.35M | 303.40M | 299.57M | 294.01M | 284.90M |
| Average Diluted Shares Outstanding | 302.50M | 303.52M | 299.63M | 294.05M | 284.94M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |